Washington, DC - A secondary analysis of the Hemodialysis (HEMO) Study highlights the significant biases in trial results that can occur when as-treated vs intention-to-treat methodology is applied [ ...
Study: At-home hemodialysis more effective than peritoneal dialysis as more options come to the fore
Peritoneal dialysis is the most common kind of at-home dialysis, given its relative convenience and ease of use compared to hemodialysis. But now, in the largest study of its kind, a massive 5-year ...
The most comprehensive, randomized clinical trial of hemodialysis therapy to-date has confirmed the adequacy of current dosage guidelines. The researchers also found that using high-flux filters to ...
Please provide your email address to receive an email when new articles are posted on . Average annual injectable drug expenditures for in-center hemodialysis were $20,000. Total annual costs were ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Patient-Centered Outcomes Research Institute (PCORI ...
In 2024, the FDA granted 510(k) clearance to a hemodialysis machine capable of delivering online high-volume hemodiafiltration. Since then, companies have started phased introduction of the system ...
Researchers receive PCORI funding to study the effectiveness of individualized model of hemodialysis
The Patient-Centered Outcomes Research Institute (PCORI) recently awarded researchers at Wake Forest University School of Medicine $10.2 million to study the effectiveness of an individualized model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results